Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Company

Transgene

Tracked across 1 events · 6 articles · First seen Apr 13, 2026 · Last active May 28, 2026

Sentiment
70
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Business
Impact: Transgene announced the completion of patient randomization in the Phase 2 part of its Phase 1/2 clinical trial for TG4050, a significant milestone for the company's individualized neoantigen therapeutic vaccine platform.
Apr 13, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Transgene live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.